Last reviewed · How we verify
levobupivacaine, clonidine
Levobupivacaine, in combination with clonidine, is a marketed anesthetic agent developed by University Hospital, Clermont-Ferrand. The key composition patent for this drug is set to expire in 2028, providing a clear period of exclusivity and potential revenue protection. The primary risk is the lack of reported key trial results and revenue data, which may limit the drug's market visibility and competitive positioning.
At a glance
| Generic name | levobupivacaine, clonidine |
|---|---|
| Sponsor | University Hospital, Clermont-Ferrand |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effectiveness of TAP Block Versus Intravenous Analgesia in Postoperative Pain Management Following Gynecologic Laparoscopic Surgery
- Pulsed Radiofrequency Therapy vs Canal Adductor Blockade in Knee Osteoarthritis
- The Effect of Local Anesthetic and Clonidine on the Cutaneous Silent Period During Spinal Anesthesia (PHASE4)
- Effectivness of Tramadol or Topic Lidocaine on Postoperative Analgesia in Laparoscopic Colorectal Resection. (NA)
- Interest in Clonidine in Association With Levobupivacaine Performing a Pudendal Block in Proctological Surgery. (PHASE4)
- Dexmedetomidine Versus Clonidine in TAP Block (PHASE2, PHASE3)
- Interest of a Bi-truncal Nerve Block (Femoral + Sciatic) Extended, Systematically Associated With General Anesthesia, in the Femoropopliteal Bypass: Study of Post-operative Analgesia and Peripheral Circulation Downstream (PHASE4)
- Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Third Trimester Medical Termination of Pregnancy Analgesia : a Randomized Study. (PCEA-IMG) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- levobupivacaine, clonidine CI brief — competitive landscape report
- levobupivacaine, clonidine updates RSS · CI watch RSS
- University Hospital, Clermont-Ferrand portfolio CI